United States · FDA National Drug Code directory

LISINOPRIL AND HYDROCHLOROTHIAZIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63187-467_41af6e44-37f8-4322-8101-9064edb4b8c1
Product NDC
63187-467
Form
TABLET
Composition / generic term
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20060410
Source listing expiry
20261231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 25 mg/1
  • LISINOPRIL — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (63187-467-00) · 63187-467-00
  • 30 TABLET in 1 BOTTLE (63187-467-30) · 63187-467-30
  • 60 TABLET in 1 BOTTLE (63187-467-60) · 63187-467-60
  • 90 TABLET in 1 BOTTLE (63187-467-90) · 63187-467-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →